| Income Statement |
| Total Revenue | 132.97K |
|
| Revenues (USD) | 132.97K |
| Cost of Revenue | 125.66K |
| Gross Profit | 7.30K |
| Operating Expenses | 5.15M |
| Research and Development Expense | 208.79K |
| Selling, General and Administrative Expense | 4.58M |
| Operating Income | -5.14M |
| Interest Expense | 158.99K |
| Net Income | -5.23M |
| Net Income Common Stock | -5.23M |
| Net Income Common Stock (USD) | -5.23M |
| Consolidated Income | -5.23M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -5.07M |
| Earning Before Interest & Taxes (USD) | -5.07M |
| Weighted Average Shares | 40.01M |
| Weighted Average Shares Diluted | 40.01M |
| Balance Sheet |
| Cash and Equivalents | 16.20M |
| Cash and Equivalents (USD) | 16.20M |
| Trade and Non-Trade Receivables | 86.46K |
| Current Assets | 16.72M |
| Property, Plant & Equipment Net | 12.70M |
| Total Assets | 45.63M |
| Debt Current | 6.82M |
| Total Debt | 6.96M |
| Current Liabilities | 10.11M |
| Debt Non-Current | 140.84K |
| Total Liabilities | 10.29M |
| Accumulated Retained Earnings (Deficit) | -51.28M |
| Accumulated Other Comprehensive Income | 41.03K |
| Shareholders Equity | 35.34M |
| Shareholders Equity (USD) | 35.34M |
| Assets Non-Current | 28.91M |
| Total Debt (USD) | 6.96M |
| Goodwill and Intangible Assets | 16.19M |
| Liabilities Non-Current | 173.09K |
| Trade and Non-Trade Payables | 3.30M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 82.43K |
| Net Cash Flow from Financing | 17.06M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.58M |
| Capital Expenditure | -1.67M |
| Issuance (Purchase) of Equity Shares | 18.39M |
| Issuance (Repayment) of Debt Securities | -930.90K |
| Net Cash Flow from Investing | -1.77M |
| Net Cash Flow from Operations | -3.76M |
| Effect of Exchange Rate Changes on Cash | 46.35K |
| Share Based Compensation | 211.12K |